Viewing Study NCT04140318


Ignite Creation Date: 2025-12-25 @ 4:46 AM
Ignite Modification Date: 2025-12-26 @ 3:47 AM
Study NCT ID: NCT04140318
Status: UNKNOWN
Last Update Posted: 2022-03-11
First Post: 2019-10-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sintilimab and Nab-paclitaxel in Second-line Treatment of Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma
Sponsor: Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module